Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01443481
Title Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | DEU | BEL

Facility Status City State Zip Country Details
University of California at Los Angeles Dept. of UCLA (4) Los Angeles California 90095 United States Details
Duke University Medical Center DUMC Durham North Carolina 27710 United States Details
Cancer Therapy & Research Center / UT Health Science Center SC San Antonio Texas 78229 United States Details
Novartis Investigative Site Gent 9000 Belgium Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Maastricht 5800 Netherlands Details
Novartis Investigative Site Singapore 119228 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field